Drug Shortage Report for APO-SUMATRIPTAN

Last updated on 2018-11-02 History
Report ID 44517
Drug Identification Number 02268388
Brand name APO-SUMATRIPTAN
Common or Proper name SUMATRIPTAN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) SUMATRIPTAN
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 6 BLS
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-04-02
Estimated end date 2018-11-30
Actual end date 2018-11-01
Shortage status Resolved
Updated date 2018-11-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2018-11-02 French Compare
v8 2018-11-02 English Compare
v7 2018-08-27 French Compare
v6 2018-08-27 English Compare
v5 2018-07-25 French Compare
v4 2018-07-25 English Compare
v3 2018-04-03 English Compare
v2 2018-04-02 French Compare
v1 2018-04-02 English Compare

Showing 1 to 9 of 9